{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:31:05Z","timestamp":1793363465999,"version":"4.5.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472174"],"award-info":[{"award-number":["82472174"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271470"],"award-info":[{"award-number":["32271470"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0520602"],"award-info":[{"award-number":["2024ZD0520602"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2023-I2M-C&T-B-016"],"award-info":[{"award-number":["2023-I2M-C&T-B-016"]}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7232117"],"award-info":[{"award-number":["7232117"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03934-6","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:16:53Z","timestamp":1766074613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Three-dimensional bioprinting of patient-derived Gastrointestinal stromal tumor: a novel platform for precision oncology and drug response profiling"],"prefix":"10.1186","volume":"24","author":[{"given":"Liwei","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zicheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuce","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingchang","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangze","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunda","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"3934_CR1","doi-asserted-by":"publisher","first-page":"iv68","DOI":"10.1093\/annonc\/mdy095","volume":"29","author":"P Casali","year":"2018","unstructured":"Casali P, Abecassis N, Bauer S, Biagini R, Bielack S, Bonvalot S, et al. Gastrointestinal stromal tumours: ESMO\u2013EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29:iv68\u201378.","journal-title":"Ann Oncol"},{"key":"3934_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.canep.2015.10.031","volume":"40","author":"K S\u00f8reide","year":"2016","unstructured":"S\u00f8reide K, Sandvik OM, S\u00f8reide JA, Giljaca V, Jureckova A, Bulusu VR. Global epidemiology of Gastrointestinal stromal tumours (GIST): a systematic review of population-based cohort studies. Cancer Epidemiol. 2016;40:39\u201346.","journal-title":"Cancer Epidemiol"},{"key":"3934_CR3","doi-asserted-by":"publisher","first-page":"5078","DOI":"10.1158\/1078-0432.CCR-20-1706","volume":"26","author":"C Serrano","year":"2020","unstructured":"Serrano C, George S. Gastrointestinal stromal tumor: challenges and opportunities for a new decade. Clin Cancer Res. 2020;26:5078\u201385.","journal-title":"Clin Cancer Res"},{"key":"3934_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41572-021-00254-5","volume":"7","author":"J-Y Blay","year":"2021","unstructured":"Blay J-Y, Kang Y-K, Nishida T, von Mehren M. Gastrointestinal stromal tumours. Nat Rev Dis Primers. 2021;7:22.","journal-title":"Nat Rev Dis Primers"},{"key":"3934_CR5","doi-asserted-by":"crossref","unstructured":"Schaefer I-M, DeMatteo RP, Serrano C. The GIST of advances in treatment of advanced gastrointestinal stromal tumor. In American Society of Clinical Oncology educational book American Society of Clinical Oncology Annual Meeting. 2022: 1.","DOI":"10.1200\/EDBK_351231"},{"key":"3934_CR6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41571-022-00606-4","volume":"19","author":"LR Klug","year":"2022","unstructured":"Klug LR, Khosroyani HM, Kent JD, Heinrich MC. New treatment strategies for advanced-stage Gastrointestinal stromal tumours. Nat Rev Clin Oncol. 2022;19:328\u201341.","journal-title":"Nat Rev Clin Oncol"},{"key":"3934_CR7","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/CCO.0000000000000642","volume":"32","author":"J Martin-Broto","year":"2020","unstructured":"Martin-Broto J, Moura DS. New drugs in Gastrointestinal stromal tumors. Curr Opin Oncol. 2020;32:314\u201320.","journal-title":"Curr Opin Oncol"},{"key":"3934_CR8","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.2217\/fon-2022-1191","volume":"19","author":"M Symcox","year":"2023","unstructured":"Symcox M, Jones RL. Ripretinib versus sunitinib in patients with advanced Gastrointestinal stromal tumor after treatment with imatinib: a plain language summary of the phase 3 INTRIGUE trial. Future Oncol. 2023;19:2383\u201393.","journal-title":"Future Oncol"},{"key":"3934_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv098","volume":"107","author":"F Meric-Bernstam","year":"2015","unstructured":"Meric-Bernstam F, Johnson A, Holla V, Bailey AM, Brusco L, Chen K, et al. A decision support framework for genomically informed investigational cancer therapy. J Natl Cancer Inst. 2015;107:djv098.","journal-title":"J Natl Cancer Inst"},{"key":"3934_CR10","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1001\/jamaoncol.2015.1313","volume":"1","author":"H Beltran","year":"2015","unstructured":"Beltran H, Eng K, Mosquera JM, Sigaras A, Romanel A, Rennert H, Kossai M, Pauli C, Faltas B, Fontugne J. Whole-exome sequencing of metastatic cancer and biomarkers of treatment response. JAMA Oncol. 2015;1:466\u201374.","journal-title":"JAMA Oncol"},{"key":"3934_CR11","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1158\/1078-0432.CCR-23-1184","volume":"29","author":"JK Dermawan","year":"2023","unstructured":"Dermawan JK, Kelly C, Gao Z, Smith S, Jadeja B, Singer S, et al. Novel genomic risk stratification model for primary gastrointestinal stromal tumors (GIST) in the adjuvant therapy era. Clin Cancer Res. 2023;29:3974\u201385.","journal-title":"Clin Cancer Res"},{"key":"3934_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2023.100959","volume":"48","author":"G Calderillo-Ru\u00edz","year":"2024","unstructured":"Calderillo-Ru\u00edz G, P\u00e9rez-Yepez EA, Garc\u00eda-G\u00e1mez MA, Millan-Catalan O, D\u00edaz-Romero C, Ugalde-Silva P, et al. Genomic profiling in GIST: implications in clinical outcome and future challenges. Neoplasia. 2024;48:100959.","journal-title":"Neoplasia"},{"key":"3934_CR13","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1126\/science.aaw6985","volume":"364","author":"D Tuveson","year":"2019","unstructured":"Tuveson D, Clevers H. Cancer modeling meets human organoid technology. Science. 2019;364:952\u20135.","journal-title":"Science"},{"key":"3934_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg3840","volume":"16","author":"JJ Sleeboom","year":"2024","unstructured":"Sleeboom JJ, van Tienderen GS, Schenke-Layland K, van der Laan LJ, Khalil AA, Verstegen MM. The extracellular matrix as hallmark of cancer and metastasis: from biomechanics to therapeutic targets. Sci Transl Med. 2024;16:eadg3840.","journal-title":"Sci Transl Med"},{"key":"3934_CR15","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41568-022-00514-w","volume":"22","author":"L Neufeld","year":"2022","unstructured":"Neufeld L, Yeini E, Pozzi S, Satchi-Fainaro R. 3D bioprinted cancer models: from basic biology to drug development. Nat Rev Cancer. 2022;22:679\u201392.","journal-title":"Nat Rev Cancer"},{"key":"3934_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41421-024-00650-7","volume":"10","author":"M Tang","year":"2024","unstructured":"Tang M, Jiang S, Huang X, Ji C, Gu Y, Qi Y, et al. Integration of 3D bioprinting and multi-algorithm machine learning identified glioma susceptibilities and microenvironment characteristics. Cell Discovery. 2024;10:39.","journal-title":"Cell Discovery"},{"key":"3934_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13205-018-1519-1","volume":"8","author":"X Wang","year":"2018","unstructured":"Wang X, Zhang X, Dai X, Wang X, Li X, Diao J, et al. Tumor-like lung cancer model based on 3D bioprinting. 3 Biotech. 2018;8:1\u20139.","journal-title":"3 Biotech"},{"key":"3934_CR18","doi-asserted-by":"crossref","unstructured":"Sun H, Wang Y, Sun M, Ke X, Li C, Jin B, Pang M, Wang Y, Jiang S, Du L. Developing Patient-Derived 3D-Bioprinting models of pancreatic cancer. J Adv Res. 2025;74:165\u201374.","DOI":"10.1016\/j.jare.2024.09.011"},{"key":"3934_CR19","doi-asserted-by":"publisher","first-page":"120416","DOI":"10.1016\/j.biomaterials.2020.120416","volume":"265","author":"F Xie","year":"2021","unstructured":"Xie F, Sun L, Pang Y, Xu G, Jin B, Xu H, Lu X, Xu Y, Du S, Wang Y. Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine. Biomaterials. 2021;265:120416.","journal-title":"Biomaterials"},{"key":"3934_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304460","volume":"11","author":"H Sun","year":"2024","unstructured":"Sun H, Sun L, Ke X, Liu L, Li C, Jin B, et al. Prediction of clinical precision chemotherapy by patient-derived 3D bioprinting models of colorectal cancer and its liver metastases. Adv Sci (Weinh). 2024;11:2304460.","journal-title":"Adv Sci (Weinh)"},{"key":"3934_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.101990","author":"T Gao","year":"2025","unstructured":"Gao T, He X, Wang J, Liu J, Hu X, Bai C, et al. Self-assembled patient-derived tumor-like cell clusters for personalized drug testing in diverse sarcomas. Cell Rep Med. 2025. https:\/\/doi.org\/10.1016\/j.xcrm.2025.101990","journal-title":"Cell Rep Med"},{"key":"3934_CR22","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.stem.2024.08.010","volume":"31","author":"A Al Shihabi","year":"2024","unstructured":"Al Shihabi A, Tebon PJ, Nguyen HTL, Chantharasamee J, Sartini S, Davarifar A, et al. The landscape of drug sensitivity and resistance in sarcoma. Cell Stem Cell. 2024;31:1524-1542. e1524.","journal-title":"Cell Stem Cell"},{"key":"3934_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13045-024-01556-3","volume":"17","author":"DJ Jung","year":"2024","unstructured":"Jung DJ, Byeon JH, Kim YC, Jeong WS, Choi J-W, Jeong GS. Generation of sarconoids from angiosarcoma patients as a systematic-based rational approach to treatment. J Hematol Oncol. 2024;17:35.","journal-title":"J Hematol Oncol"},{"key":"3934_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw520","volume":"44","author":"R Shen","year":"2016","unstructured":"Shen R, Seshan VE. FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. Nucleic Acids Res. 2016;44:e131-e131.","journal-title":"Nucleic Acids Res"},{"key":"3934_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41467-017-00050-4","volume":"8","author":"SME Sahraeian","year":"2017","unstructured":"Sahraeian SME, Mohiyuddin M, Sebra R, Tilgner H, Afshar PT, Au KF, Bani Asadi N, Gerstein MB, Wong WH, Snyder MP. Gaining comprehensive biological insight into the transcriptome by performing a broad-spectrum RNA-seq analysis. Nat Commun. 2017;8:59.","journal-title":"Nat Commun"},{"key":"3934_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18:220.","journal-title":"Genome Biol"},{"key":"3934_CR27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u201347.","journal-title":"Eur J Cancer"},{"key":"3934_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-017-3150-7","volume":"17","author":"Y Luo","year":"2017","unstructured":"Luo Y, Chen J, Huang K, Lin Y, Chen M, Xu L, Li Z-P, Feng S-T. Early evaluation of Sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi criteria? BMC Cancer. 2017;17:1\u201310.","journal-title":"BMC Cancer"},{"key":"3934_CR29","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1200\/JCO.2006.07.3049","volume":"25","author":"H Choi","year":"2007","unstructured":"Choi H, Charnsangavej C, Faria SC, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Benjamin RS. Correlation of computed tomography and positron emission tomography in patients with metastatic Gastrointestinal stromal tumor treated at a single institution with Imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol. 2007;25:1753\u20139.","journal-title":"J Clin Oncol"},{"key":"3934_CR30","unstructured":"Jenks GF. Optimal data classification for choropleth maps. Department of Geographiy, University of Kansas Occasional Paper 1977."},{"key":"3934_CR31","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1158\/1078-0432.CCR-20-4116","volume":"28","author":"JE Grossman","year":"2022","unstructured":"Grossman JE, Muthuswamy L, Huang L, Akshinthala D, Perea S, Gonzalez RS, Tsai LL, Cohen J, Bockorny B, Bullock AJ. Organoid sensitivity correlates with therapeutic response in patients with pancreatic cancer. Clin Cancer Res. 2022;28:708\u201318.","journal-title":"Clin Cancer Res"},{"key":"3934_CR32","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1136\/gutjnl-2019-319960","volume":"70","author":"H Yang","year":"2021","unstructured":"Yang H, Sun L, Pang Y, Hu D, Xu H, Mao S, Peng W, Wang Y, Xu Y, Zheng Y-C. Three-dimensional bioprinted hepatorganoids prolong survival of mice with liver failure. Gut. 2021;70:567\u201374.","journal-title":"Gut"},{"key":"3934_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ado1550","volume":"10","author":"B Deng","year":"2024","unstructured":"Deng B, Ma Y, Huang J, He R, Luo M, Mao L, et al. Revitalizing liver function in mice with liver failure through transplantation of 3D-bioprinted liver with expanded primary hepatocytes. Sci Adv. 2024;10:eado1550.","journal-title":"Sci Adv"},{"key":"3934_CR34","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S1470-2045(11)70299-6","volume":"13","author":"H Joensuu","year":"2012","unstructured":"Joensuu H, Vehtari A, Riihim\u00e4ki J, Nishida T, Steigen SE, Brabec P, Plank L, Nilsson B, Cirilli C, Braconi C. Risk of recurrence of Gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol. 2012;13:265\u201374.","journal-title":"Lancet Oncol"},{"key":"3934_CR35","unstructured":"O\u2019Connell C, Onofrillo C, Duchi S, Li X, Zhang Y, Tian P, Lu L, Trengove A, Quigley A, Gambhir S. Evaluation of sterilisation methods for bio-ink components: gelatin. 2019."},{"key":"3934_CR36","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/jbm.b.33863","volume":"106","author":"A Souness","year":"2018","unstructured":"Souness A, Zamboni F, Walker GM, Collins MN. Influence of scaffold design on 3 D printed cell constructs. J Biomedical Mater Res Part B: Appl Biomaterials. 2018;106:533\u201345.","journal-title":"J Biomedical Mater Res Part B: Appl Biomaterials"},{"key":"3934_CR37","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.biomaterials.2015.08.045","volume":"73","author":"K Yue","year":"2015","unstructured":"Yue K, Trujillo-de Santiago G, Alvarez MM, Tamayol A, Annabi N, Khademhosseini A. Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels. Biomaterials. 2015;73:254\u201371.","journal-title":"Biomaterials"},{"key":"3934_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202200364","volume":"18","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wang Z, Hu Q, Luo H, Lu B, Gao Y, et al. 3D bioprinted GelMA-nanoclay hydrogels induce colorectal cancer stem cells through activating wnt\/\u03b2\u2010catenin signaling. Small. 2022;18:2200364.","journal-title":"Small"},{"key":"3934_CR39","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1038\/s41467-024-47737-z","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Hu Q, Pei Y, Luo H, Wang Z, Xu X, Zhang Q, Dai J, Wang Q, Fan Z. A patient-specific lung cancer assembloid model with heterogeneous tumor microenvironments. Nat Commun. 2024;15:3382.","journal-title":"Nat Commun"},{"key":"3934_CR40","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/s41422-020-0338-1","volume":"30","author":"M Tang","year":"2020","unstructured":"Tang M, Xie Q, Gimple RC, Zhong Z, Tam T, Tian J, Kidwell RL, Wu Q, Prager BC, Qiu Z. Three-dimensional bioprinted glioblastoma microenvironments model cellular dependencies and immune interactions. Cell Res. 2020;30:833\u201353.","journal-title":"Cell Res"},{"key":"3934_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101627","volume":"5","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Li S, Zhu L, Huang M, Xie Y, Song X, et al. Personalized drug screening using patient-derived organoid and its clinical relevance in gastric cancer. Cell Rep Med. 2024;5:101627.","journal-title":"Cell Rep Med"},{"key":"3934_CR42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov LB, Kim J, Haradhvala NJ, Huang MN, Tian Ng AW, Wu Y, Boot A, Covington KR, Gordenin DA, Bergstrom EN. The repertoire of mutational signatures in human cancer. Nature. 2020;578:94\u2013101.","journal-title":"Nature"},{"key":"3934_CR43","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate JG, Bamford S, Jubb HC, Sondka Z, Beare DM, Bindal N, Boutselakis H, Cole CG, Creatore C, Dawson E. COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res. 2019;47:D941\u20137.","journal-title":"Nucleic Acids Res"},{"key":"3934_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.764275","volume":"9","author":"Y Feng","year":"2021","unstructured":"Feng Y, Yao S, Pu Z, Cheng H, Fei B, Zou J, et al. Identification of new tumor-related gene mutations in Chinese gastrointestinal stromal tumors. Front Cell Dev Biol. 2021;9:764275.","journal-title":"Front Cell Dev Biol"},{"key":"3934_CR45","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41374-019-0322-x","volume":"100","author":"P Li","year":"2020","unstructured":"Li P, Li M, Wang K, Liu Y, Wang Y, Zhao D, et al. Genetic alterations in cell cycle regulation-associated genes may promote primary progression of gastrointestinal stromal tumors. Lab Invest. 2020;100:426\u201337.","journal-title":"Lab Invest"},{"key":"3934_CR46","doi-asserted-by":"publisher","first-page":"9495","DOI":"10.1038\/s41467-024-53821-1","volume":"15","author":"F Xie","year":"2024","unstructured":"Xie F, Luo S, Liu D, Lu X, Wang M, Liu X, et al. Genomic and transcriptomic landscape of human gastrointestinal stromal tumors. Nat Commun. 2024;15:9495.","journal-title":"Nat Commun"},{"key":"3934_CR47","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1053\/j.gastro.2021.08.023","volume":"161","author":"P Nallasamy","year":"2021","unstructured":"Nallasamy P, Nimmakayala RK, Karmakar S, Leon F, Seshacharyulu P, Lakshmanan I, Rachagani S, Mallya K, Zhang C, Ly QP. Pancreatic tumor microenvironment factor promotes cancer stemness via SPP1\u2013CD44 axis. Gastroenterology. 2021;161:1998\u20132013. e1997.","journal-title":"Gastroenterology"},{"key":"3934_CR48","doi-asserted-by":"publisher","first-page":"448","DOI":"10.62347\/UAKN9541","volume":"14","author":"Y-H Hung","year":"2024","unstructured":"Hung Y-H, Wang H-C, Hsu S-H, Wang L-Y, Tsai Y-L, Su Y-Y, Hung W-C, Chen L-T. Neuron-derived neurotensin promotes pancreatic cancer invasiveness and gemcitabine resistance via the NTSR1\/Akt pathway. Am J Cancer Res. 2024;14:448.","journal-title":"Am J Cancer Res"},{"key":"3934_CR49","doi-asserted-by":"publisher","first-page":"5315","DOI":"10.1038\/s41467-020-18951-2","volume":"11","author":"I Rodriguez-Hernandez","year":"2020","unstructured":"Rodriguez-Hernandez I, Maiques O, Kohlhammer L, Cantelli G, Perdrix-Rosell A, Monger J, Fanshawe B, Bridgeman VL, Karagiannis SN, Penin RM. WNT11-FZD7-DAAM1 signalling supports tumour initiating abilities and melanoma amoeboid invasion. Nat Commun. 2020;11:5315.","journal-title":"Nat Commun"},{"key":"3934_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-021-02187-z","volume":"40","author":"K Menck","year":"2021","unstructured":"Menck K, Heinrichs S, Wlochowitz D, Sitte M, Noeding H, Janshoff A, et al. WNT11\/ROR2 signaling is associated with tumor invasion and poor survival in breast cancer. J Exp Clin Cancer Res. 2021;40:1\u201318.","journal-title":"J Exp Clin Cancer Res"},{"key":"3934_CR51","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.ejso.2020.02.036","volume":"46","author":"K Fujiya","year":"2020","unstructured":"Fujiya K, Ohshima K, Kitagawa Y, Hatakeyama K, Nagashima T, Aizawa D, et al. Aberrant expression of Wnt\/\u03b2-catenin signaling pathway genes in aggressive malignant gastric gastrointestinal stromal tumors. Eur J Surg Oncol. 2020;46:1080\u20137.","journal-title":"Eur J Surg Oncol"},{"key":"3934_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-025-03320-y","volume":"44","author":"Y Cui","year":"2025","unstructured":"Cui Y, Cao X, Zhang Y, Fu C, Li D, Sun Y, et al. Protein phosphatase 1 regulatory subunit 15 A (PPP1R15A) promoted the progression of gastric cancer by activating cell autophagy under energy stress. J Exp Clin Cancer Res. 2025;44:52.","journal-title":"J Exp Clin Cancer Res"},{"key":"3934_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101177","author":"Y Chen","year":"2023","unstructured":"Chen Y, Huo R, Kang W, Liu Y, Zhao Z, Fu W, et al. Tumor-associated monocytes promote mesenchymal transformation through EGFR signaling in glioma. Cell Rep Med. 2023;2023;4(9). https:\/\/doi.org\/10.1016\/j.xcrm.2023.101177","journal-title":"Cell Rep Med"},{"key":"3934_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02139-6","volume":"23","author":"A Naik","year":"2025","unstructured":"Naik A, Thomas R, Al-Khalifa A, Qasem H, Decock J. Immunomodulatory effects of tumor Lactate Dehydrogenase C (LDHC) in breast cancer. Cell Commun Signal. 2025;23:145.","journal-title":"Cell Commun Signal"},{"key":"3934_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228842","volume":"21","author":"S Boichuk","year":"2020","unstructured":"Boichuk S, Bikinieva F, Nurgatina I, Dunaev P, Valeeva E, Aukhadieva A, et al. Inhibition of AKT-signaling sensitizes soft tissue sarcomas (STS) and gastrointestinal stromal tumors (GIST) to doxorubicin via targeting of homology-mediated DNA repair. Int J Mol Sci. 2020;21:8842.","journal-title":"Int J Mol Sci"},{"key":"3934_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119389","author":"L Cao","year":"2025","unstructured":"Cao L, Li Z, Huang Y, Chen H, Chen L, Tao L, et al. Huaier inhibits the proliferation and migration of gastrointestinal stromal tumors by regulating the JAK2\/STAT3 signaling pathway. J Ethnopharmacol. 2025, 342:119389. https:\/\/doi.org\/10.1016\/j.jep.2025.119389","journal-title":"J Ethnopharmacol"},{"key":"3934_CR57","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41419-024-07241-0","volume":"15","author":"C Liu","year":"2024","unstructured":"Liu C, Ge H, Shen C, Hu D, Zhao X, Qin R, Wang Y. NOTCH3 promotes malignant progression of bladder cancer by directly regulating SPP1 and activating PI3K\/AKT pathway. Cell Death Dis. 2024;15:840.","journal-title":"Cell Death Dis"},{"key":"3934_CR58","doi-asserted-by":"publisher","DOI":"10.1172\/JCI146186","author":"J Qian","year":"2021","unstructured":"Qian J, LeSavage BL, Hubka KM, Ma C, Natarajan S, Eggold JT, et al. Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling. J Clin Invest. 2021;131(16) . https:\/\/doi.org\/10.1172\/JCI146186","journal-title":"J Clin Invest"},{"key":"3934_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04063-0","volume":"21","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Weng Z, Zhou X, Xu Z, Cao B, Wang B, et al. Mesenchymal stromal cells promote the drug resistance of gastrointestinal stromal tumors by activating the PI3K-AKT pathway via TGF-\u03b22. J Transl Med. 2023;21:219.","journal-title":"J Transl Med"},{"key":"3934_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-014-0444-3","volume":"32","author":"J Li","year":"2015","unstructured":"Li J, Dang Y, Gao J, Li Y, Zou J, Shen L. PI3K\/AKT\/mTOR pathway is activated after Imatinib secondary resistance in Gastrointestinal stromal tumors (GISTs). Med Oncol. 2015;32:1\u20137.","journal-title":"Med Oncol"},{"key":"3934_CR61","first-page":"532","volume":"41","author":"Z-W Long","year":"2018","unstructured":"Long Z-W, Wu J-H, Wang Y-N, Zhou Y. MiR-374b promotes proliferation and inhibits apoptosis of human GIST cells by inhibiting PTEN through activation of the PI3K\/Akt pathway. Mol Cells. 2018;41:532\u201344.","journal-title":"Mol Cells"},{"key":"3934_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01168-8","volume":"7","author":"Y Yang","year":"2022","unstructured":"Yang Y, Li S, Wang Y, Zhao Y, Li Q. Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective. Signal Transduct Target Ther. 2022;7:329.","journal-title":"Signal Transduct Target Ther"},{"key":"3934_CR63","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1093\/annonc\/mdy309","volume":"29","author":"M Hemming","year":"2018","unstructured":"Hemming M, Heinrich M, Bauer S, George S. Translational insights into Gastrointestinal stromal tumor and current clinical advances. Ann Oncol. 2018;29:2037\u201345.","journal-title":"Ann Oncol"},{"key":"3934_CR64","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/path.2382","volume":"216","author":"B Liegl","year":"2008","unstructured":"Liegl B, Kepten I, Le C, Zhu M, Demetri G, Heinrich M, Fletcher C, Corless C, Fletcher J. Heterogeneity of kinase inhibitor resistance mechanisms in GIST. J Pathology: J Pathological Soc Great Br Irel. 2008;216:64\u201374.","journal-title":"J Pathology: J Pathological Soc Great Br Irel"},{"key":"3934_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01411-x","volume":"22","author":"S Zhou","year":"2024","unstructured":"Zhou S, Abdihamid O, Tan F, Zhou H, Liu H, Li Z, et al. KIT mutations and expression: current knowledge and new insights for overcoming IM resistance in GIST. Cell Commun Signal. 2024;22:153.","journal-title":"Cell Commun Signal"},{"key":"3934_CR66","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-024-01272-7","author":"C He","year":"2024","unstructured":"He C, Wang Z, Yu J, Mao S, Xiang X. Current drug resistance mechanisms and treatment options in gastrointestinal stromal tumors: summary and update. Curr Treat Options Oncol. 2024, 25:1390-1405. . https:\/\/doi.org\/10.1007\/s11864-024-01272-7","journal-title":"Curr Treat Options Oncol"},{"key":"3934_CR67","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.694","volume":"5","author":"X Ou","year":"2024","unstructured":"Ou X, Gao G, Habaz IA, Wang Y. Mechanisms of resistance to tyrosine kinase inhibitor-targeted therapy and overcoming strategies. MedComm. 2024;5:e694.","journal-title":"MedComm"},{"key":"3934_CR68","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41419-024-06571-3","volume":"15","author":"X Liu","year":"2024","unstructured":"Liu X, Yu J, Li Y, Shi H, Jiao X, Liu X, et al. Deciphering the tumor immune microenvironment of imatinib-resistance in advanced gastrointestinal stromal tumors at single-cell resolution. Cell Death Dis. 2024;15:190.","journal-title":"Cell Death Dis"},{"key":"3934_CR69","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.tibtech.2015.06.007","volume":"33","author":"S Knowlton","year":"2015","unstructured":"Knowlton S, Onal S, Yu CH, Zhao JJ, Tasoglu S. Bioprinting for cancer research. Trends Biotechnol. 2015;33:504\u201313.","journal-title":"Trends Biotechnol"},{"key":"3934_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202200690","volume":"11","author":"M Jung","year":"2022","unstructured":"Jung M, Ghamrawi S, Du EY, Gooding JJ, Kavallaris M. Advances in 3D bioprinting for cancer biology and precision medicine: from matrix design to application. Adv Healthc Mater. 2022;11:2200690.","journal-title":"Adv Healthc Mater"},{"key":"3934_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202407871","author":"J Han","year":"2025","unstructured":"Han J, Jeong HJ, Choi J, Kim H, Kwon T, Myung K, et al. Bioprinted patient-derived organoid arrays capture intrinsic and extrinsic tumor features for advanced personalized medicine. Adv Sci. 2025, 12:2407871. https:\/\/doi.org\/10.1002\/advs.202407871","journal-title":"Adv Sci"},{"key":"3934_CR72","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202411769","author":"Ym Choi","year":"2025","unstructured":"Choi Ym, Na D, Yoon G, Kim J, Min S, Yi HG, et al. Prediction of patient drug response via 3D bioprinted gastric cancer model utilized patient-derived tissue laden tissue\u2010specific bioink. Adv Sci. 2025, 12:2411769. https:\/\/doi.org\/10.1002\/advs.202411769","journal-title":"Adv Sci"},{"key":"3934_CR73","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1038\/s41467-023-38832-8","volume":"14","author":"PJ Tebon","year":"2023","unstructured":"Tebon PJ, Wang B, Markowitz AL, Davarifar A, Tsai BL, Krawczuk P, et al. Drug screening at single-organoid resolution via bioprinting and interferometry. Nat Commun. 2023;14:3168.","journal-title":"Nat Commun"},{"key":"3934_CR74","doi-asserted-by":"publisher","first-page":"101015","DOI":"10.1016\/j.tranon.2021.101015","volume":"14","author":"R Augustine","year":"2021","unstructured":"Augustine R, Kalva SN, Ahmad R, Zahid AA, Hasan S, Nayeem A, et al. 3D bioprinted cancer models: revolutionizing personalized cancer therapy. Transl Oncol. 2021;14:101015.","journal-title":"Transl Oncol"},{"key":"3934_CR75","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/1758834012450935","volume":"4","author":"D Kee","year":"2012","unstructured":"Kee D, Zalcberg JR. Current and emerging strategies for the management of imatinib-refractory advanced gastrointestinal stromal tumors. Ther Adv Med Oncol. 2012;4:255\u201370.","journal-title":"Ther Adv Med Oncol"},{"key":"3934_CR76","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1158\/1078-0432.CCR-14-3120","volume":"21","author":"CR Antonescu","year":"2015","unstructured":"Antonescu CR, DeMatteo RP. CCR 20th anniversary commentary: a genetic mechanism of Imatinib resistance in gastrointestinal stromal tumor\u2014where are we a decade later? Clin Cancer Res. 2015;21:3363\u20135.","journal-title":"Clin Cancer Res"},{"key":"3934_CR77","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.3390\/cancers15072074","volume":"15","author":"F Catalano","year":"2023","unstructured":"Catalano F, Cremante M, Dalmasso B, Pirrone C, Lagodin D\u2019Amato A, Grassi M, et al. Molecular tailored therapeutic options for advanced gastrointestinal stromal tumors (GISTs): current practice and future perspectives. Cancers. 2023;15:2074.","journal-title":"Cancers"},{"key":"3934_CR78","doi-asserted-by":"publisher","DOI":"10.1177\/17562848211008177","volume":"14","author":"JR Zalcberg","year":"2021","unstructured":"Zalcberg JR. Ripretinib for the treatment of advanced gastrointestinal stromal tumor. Ther Adv Gastroenterol. 2021;14:17562848211008177.","journal-title":"Ther Adv Gastroenterol"},{"key":"3934_CR79","doi-asserted-by":"crossref","unstructured":"Liu X, Yu J, Li Y, Shi H, Jiao X, Liu X, Guo D, Li Z, Tian Y, Dai FJCD. Disease: Deciphering the tumor immune microenvironment of imatinib-resistance in advanced Gastrointestinal stromal tumors at single-cell resolution. Cell Death Dis. 2024, 15:190.","DOI":"10.1038\/s41419-024-06571-3"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03934-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03934-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03934-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T13:03:08Z","timestamp":1769173388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-025-03934-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3934"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03934-6","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Review Committee of Peking Union Medical College Hospital (Approval No. I-25PJ0659). All procedures adhered to the ethical guidelines of the Declaration of Helsinki and the International Conference on Harmonisation\u2019s Good Clinical Practice. Histopathological postoperative analysis was conducted to verify the presence of GIST in all participants, and written informed consent was obtained from each subject prior to study enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}